ARMP

3.0301.68%
SJ

Sarah J. Schlesinger

Independent Director

Dr. Sarah J. Schlesinger, M.D., serves as Director at Gate Neurosciences, Inc. since May 2023. She serves as Director at Armata Pharmaceuticals, Inc. since February 12, 2020. She served as Director of Egenesis Inc. Dr. Schlesinger has been an Independent Director of Innoviva Inc. since February 13, 2018. She served as a Director of Ariad Pharmaceuticals, Inc. from July 17, 2013 to February 16, 2017. She has been Member of Scientific Advisory Board at Lycera Corp. since November 10, 2016. Dr. Schlesinger served as a Director of The Medicines Company from February 2018 to January 6, 2020. Dr. Schlesinger’s research has focused on the clinical manipulation of the immune system's dendritic cells to elicit immunity to cancer and HIV. She has designed and conducted clinical trials employing the techniques of immunology and dendritic-cell biology, which have led to a better understanding of human diseases and their potential treatments. In addition to leading clinical trials at the Rockefeller University Hospital, she is Co-Director of the University's Clinical Scholars program and the Certificate in Clinical and Translational Sciences program. She Chairs the research education of the Center for Clinical and Translational Science at Rockefeller. Widely published in her field, Dr. Schlesinger has been recognized with numerous awards for her research and teaching. She is Senior Attending Physician at Rockefeller University Hospital. Dr. Schlesinger was The Clinical Director of the laboratory of Dr. Ralph Steinman (Nobel Laureate 2011) from 2002 until 2011. Dr. Schlesinger led the Dendritic Cell section of the Division of Retrovirology at the Walter Reed Army Institute of Research and was also a Member of the Division of Infectious and Parasitic Disease Pathology at the Armed Forces Institute of Pathology from 1994 to 2002. In 2002, Dr. Schlesinger rejoined Rockefeller University and began working with the International AIDS Vaccine Initiative as a Scientist in Vaccine Research and Design. Dr. Schlesinger previously served as IRB vice-Chairperson. In 2017 she assumed the position of Chairperson of the IRB. She is currently the Director of the education and training programs at Rockefeller University Center for Clinical and Translational Science. Dr. Schlesinger currently serves on the Board of two non-profit organizations: the AIDS Vaccines Advocacy Coalition and The Hastings Center, the pre-eminent center for the study of bioethics. Dr. Schlesinger served as an independent corporate Director of Ariad Pharmaceuticals from 2013 until its sale to Takeda Pharmaceutical Company Limited in 2017. She was Clinical Director of The Laboratory of Molecular Immunology, Senior Physician, The Rockefeller University Hospital. She trained in surgery at the Albert Einstein College of Medicine from 1985 to 1987) and in pathology at the New York Hospital from 1987 to 1990, where she served as Chief resident. She held faculty positions at Cornell University Medical College from 1990 to 1991, State University of New York at Buffalo from 1991 to 1994 and Georgetown University School of Medicine from 1995 to 2002. In 1996, she became a research physician in the Division of Retrovirology at the Walter Reed Army Institute of Research and then worked as a scientist in vaccine research at the International AIDS Vaccine Initiative. In 2002, she joined Rockefeller University as a Member of the adjunct faculty in the Laboratory of Cellular Physiology and Immunology and then in 2003, she was appointed as a research associate professor with a joint appointment at the Aaron Diamond AIDS Research Center. In 2007, she became associate professor of clinical investigation at Rockefeller University and clinical Director of the Steinman laboratory. She trained in Anatomic Pathology at The New York Hospital where she served as Chief Resident. Dr. Schlesinger received her Bachelors of Arts Degree from Wellesley College and her M.D. degree from Rush Medical College.

Positions